Monday 16 Jun, 2025 12:27 PM
Site map | Locate Us | Login
   Omaxe gains on Rs 1,000-cr new Amritsar township launch    Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations    KBC Global Ltd leads gainers in 'B' group    Sterlite Technologies Ltd leads gainers in 'A' group    TCS gains on inking multinational deal with Salling Group    Spicejet gains as Q4 PAT zooms 173% YoY to Rs 325 cr    Lupin inks licensing deal with Sino Universal pharma for Tiotropium DPI drug in China    Volumes jump at FDC Ltd counter    HBL Engineering rises after securing Rs 133-cr railway contract for Kavach safety system    NSE SME Sacheerome hits high notes on debut    B R Goyal Infra bags Rs 4-cr work order from NHDC    Tata Motors tumbles on weak JLR outlook    Sun Pharma appoints Kirti Ganorkar as new MD    Sterlite Tech jumps after launching AI-driven data centre solutions    Godrej Properties acquires 14-Acre land in East Bengaluru 
Saravan Stocks
       
Company Background
Gland Pharma Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
543245 INE068V01023 592.092596 GLAND 1.07 27832.3 25.54 66.14 1
Incorporation Year 1978  
Registered Office Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal,
Hyderabad,
Telangana-500043
Telephone 91-40-30510999  
Fax 91-40-30510800  
Chairman Yiu Kwan Stanley Lau  
Managing Director SRINIVAS SADU  
Company Secretary NA  
Auditor Deloitte Haskins & Sells  
Face Value 1  
Market Lot 1  
Listing BSE,NSE  
Registrar MUFG Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083
 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41984852
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited